GLTO vs NBIX · $1.73B cap vs P/E 45, rev $1.77B
Galecto Inc (GLTO) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
Galecto Inc (GLTO) is a biotechnology company listed on NASDAQ.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
GLTO does not have a complete income-statement cache yet.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
GLTO currently screens at market cap $1.73B. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the GLTO and NBIX stock pages for the full models.
Not investment advice.